Krista Rombouts, PhD, Professor and Interim Head of Department – Institute for Liver and Digestive Health – University College London (UCL), UK. Current research interests are extracellular matrix and organ fibrogenesis in diseases: Hepatic Stellate Cell behaviour; liver cancer cell – fibrotic stroma cell interaction; liver metastasis; MASH – MASLD; fibrosis development in Small Intestinal Neuroendocrine tumours (SI-NET) and neuroendocrine carcinomas (NECs); and innovative 3D ECM cell culture – human biomaterial systems for improvement of new target identification and drug development.
Prof Rombouts has over 80 publications in international peer reviewed scientific Journals with over 7000 citations and h-index 45, i10-index of 73. Prof Rombouts has given invited seminars at universities, pharmaceutical companies, and national/international congresses. Prof Rombouts was Editorial Board Member of American Journal of Pathology and Journal of Hepatology. Prof Rombouts is Educational Committee member of the European Association for Study of the Liver (EASL). She is shareholder and consultant of UCL Spin-out Engitix Therapeutics Ltd since 2016 and has international academic collaborators and industrial partners.